Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Leukemia

  Free Subscription


06.03.2017

1 Am J Clin Pathol
1 Ann Hematol
4 Blood
1 Cancer
1 Cell
3 J Pediatr Hematol Oncol
2 J Virol
1 Leuk Res
4 Leukemia
3 N Engl J Med


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Am J Clin Pathol

  1. GARDNER JA, Peterson JD, Turner SA, Soares BL, et al
    Detection of CALR Mutation in Clonal and Nonclonal Hematologic Diseases Using Fragment Analysis and Next-Generation Sequencing.
    Am J Clin Pathol. 2016;146:448-55.
    PubMed     Text format     Abstract available


    Ann Hematol

  2. GAO N, Wang XX, Sun JR, Yu WZ, et al
    Clinical impact of galectin-3 in newly diagnosed t (15;17)(q22;q21)/PML-RARa acute promyelocytic leukemia treated with all-trans retinoic acid and arsenic trioxide-based regimens.
    Ann Hematol. 2017 Feb 25. doi: 10.1007/s00277-017-2948.
    PubMed     Text format     Abstract available


    Blood

  3. TASIAN SK, Kenderian SS, Shen F, Ruella M, et al
    Optimized Depletion of Chimeric Antigen Receptor T-Cells in Murine Xenograft Models of Human Acute Myeloid Leukemia.
    Blood. 2017 Feb 28. pii: blood-2016-08-736041. doi: 10.1182/blood-2016-08-736041
    PubMed     Text format     Abstract available

  4. MONTALBAN-BRAVO G, Benton CB, Wang SA, Ravandi F, et al
    Greater than one TP53 abnormality is a dominant characteristic of pure erythroid leukemia.
    Blood. 2017 Feb 28. pii: blood-2016-11-749903. doi: 10.1182/blood-2016-11-749903
    PubMed     Text format    

  5. DANESHBOD Y, Medeiros LJ
    Dermal myeloid sarcoma as an initial presentation of acute myeloid leukemia.
    Blood. 2017;129:1056.
    PubMed     Text format    

  6. NAUDIN C, Hattabi A, Michelet F, Miri-Nezhad A, et al
    PUMILIO/FOXP1 signaling drives expansion of hematopoietic stem/progenitor and leukemia cells.
    Blood. 2017 Feb 23. pii: blood-2016-10-747436. doi: 10.1182/blood-2016-10-747436
    PubMed     Text format     Abstract available


    Cancer

  7. KONG JH, Winton EF, Heffner LT, Chen Z, et al
    Does the frequency of molecular monitoring after tyrosine kinase inhibitor discontinuation affect outcomes of patients with chronic myeloid leukemia?
    Cancer. 2017 Feb 27. doi: 10.1002/cncr.30608.
    PubMed     Text format     Abstract available


    Cell

  8. TOTHOVA Z, Ebert BL
    Doubling Down on Mutant RAS Can MEK or Break Leukemia.
    Cell. 2017;168:749-750.
    PubMed     Text format     Abstract available


    J Pediatr Hematol Oncol

  9. DEMIRSOY U, Sarper N, Aylan Gelen S, Zengin E, et al
    The Association of Oral Vitamin D and Calcium Supplementation With Bone Mineral Density in Pediatric Acute Lymphoblastic Leukemia Patients.
    J Pediatr Hematol Oncol. 2017 Feb 23. doi: 10.1097/MPH.0000000000000797.
    PubMed     Text format     Abstract available

  10. AL OMAR S, Anabtawi N, Al Qasem W, Rihani R, et al
    Bacterial Infections in Children With Acute Myeloid Leukemia Receiving Ciprofloxacin Prophylaxis.
    J Pediatr Hematol Oncol. 2017 Feb 23. doi: 10.1097/MPH.0000000000000792.
    PubMed     Text format     Abstract available

  11. NAZIR HF, Elshinawy M, AlRawas A, Khater D, et al
    Efficacy and Safety of Dapsone Versus Trimethoprim/Sulfamethoxazol for Pneumocystis Jiroveci Prophylaxis in Children With Acute Lymphoblastic Leukemia With a Background of Ethnic Neutropenia.
    J Pediatr Hematol Oncol. 2017 Feb 23. doi: 10.1097/MPH.0000000000000804.
    PubMed     Text format     Abstract available


    J Virol

  12. OPAZO T, Garces A, Tapia D, Barraza F, et al
    Functional evidence of the involvement of the dynein light chain DYNLRB2 in murine leukemia virus infection.
    J Virol. 2017 Mar 1. pii: JVI.00129-17. doi: 10.1128/JVI.00129.
    PubMed     Text format     Abstract available

  13. REUTER N, Schilling EM, Scherer M, Muller R, et al
    The ND10 component promyelocytic leukemia protein acts as an E3 ligase for SUMOylation of the major immediate-early protein IE1 of human cytomegalovirus.
    J Virol. 2017 Mar 1. pii: JVI.02335-16. doi: 10.1128/JVI.02335.
    PubMed     Text format     Abstract available


    Leuk Res

  14. YAN T, Leng Y, Yang X, Gong Y, et al
    High-expressing cystic fibrosis transmembrane conductance regulator interacts with histone deacetylase 2 to promote the development of Ph+ leukemia through the HDAC2-mediated PTEN pathway.
    Leuk Res. 2017;57:9-19.
    PubMed     Text format     Abstract available


    Leukemia

  15. HAN SH, Kim SH, Kim HJ, Lee Y, et al
    Cobll1 is linked to drug resistance and blastic transformation in chronic myeloid leukemia.
    Leukemia. 2017 Feb 24. doi: 10.1038/leu.2017.
    PubMed     Text format     Abstract available

  16. HUSSEIN K, Stucki-Koch A, Gohring G, Kreipe H, et al
    Increased megakaryocytic proliferation, pro-platelet deposition and expression of fibrosis-associated factors in children with chronic myeloid leukemia with bone marrow fibrosis.
    Leukemia. 2017 Feb 27. doi: 10.1038/leu.2017.
    PubMed     Text format     Abstract available

  17. CHATURVEDI A, Herbst L, Pusch S, Klett L, et al
    Pan-mutant-IDH1 inhibitor BAY1436032 is highly effective against human IDH1 mutant acute myeloid leukemia in vivo.
    Leukemia. 2017 Feb 24. doi: 10.1038/leu.2017.
    PubMed     Text format     Abstract available

  18. LEHMANN S, Deneberg S, Antunovic P, Rangert-Derolf A, et al
    Early death rates remain high in high-risk APL. Update from the Swedish acute leukemia registry 1997-2013.
    Leukemia. 2017 Feb 24. doi: 10.1038/leu.2017.
    PubMed     Text format     Abstract available


    N Engl J Med

  19. KANTARJIAN H, Stein A, Gokbuget N, Fielding AK, et al
    Blinatumomab versus Chemotherapy for Advanced Acute Lymphoblastic Leukemia.
    N Engl J Med. 2017;376:836-847.
    PubMed     Text format     Abstract available

  20. MONTALBAN-BRAVO G, Takahashi K, Garcia-Manero G
    Decitabine in TP53-Mutated AML.
    N Engl J Med. 2017;376:796-7.
    PubMed     Text format    

  21. WELCH JS, Petti AA, Ley TJ
    Decitabine in TP53-Mutated AML.
    N Engl J Med. 2017;376:797-8.
    PubMed     Text format    


Thank you for your interest in scientific medicine.


AMEDEO Leukemia is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: